Merck & Co., Inc. (MRK)
146.73
-0.21
(-0.14%)
USD |
NYSE |
Nov 06, 16:00
146.72
-0.01
(-0.01%)
Pre-Market: 20:00
Merck Cash from Investing (Quarterly) : -1.319B for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -1.319B |
| June 30, 2026 | -5.602B |
| March 31, 2026 | -10.21B |
| December 31, 2025 | -11.20B |
| September 30, 2025 | -283.00M |
| June 30, 2025 | -770.00M |
| March 31, 2025 | -1.487B |
| December 31, 2024 | -1.444B |
| September 30, 2024 | -3.845B |
| June 30, 2024 | -1.069B |
| March 31, 2024 | -1.376B |
| December 31, 2023 | 53.00M |
| September 30, 2023 | -334.00M |
| June 30, 2023 | -11.44B |
| March 31, 2023 | -2.359B |
| December 31, 2022 | -1.748B |
| September 30, 2022 | -962.00M |
| June 30, 2022 | -1.077B |
| March 31, 2022 | -1.173B |
| December 31, 2021 | -12.05B |
| September 30, 2021 | -1.061B |
| June 30, 2021 | -2.811B |
| March 31, 2021 | -634.00M |
| December 31, 2020 | -4.778B |
| September 30, 2020 | -2.155B |
| Date | Value |
|---|---|
| June 30, 2020 | -882.00M |
| March 31, 2020 | -1.628B |
| December 31, 2019 | -763.00M |
| September 30, 2019 | 191.00M |
| June 30, 2019 | -2.425B |
| March 31, 2019 | 368.00M |
| December 31, 2018 | 2.178B |
| September 30, 2018 | 1.66B |
| June 30, 2018 | 673.00M |
| March 31, 2018 | -197.00M |
| December 31, 2017 | -58.00M |
| September 30, 2017 | 671.00M |
| June 30, 2017 | -1.127B |
| March 31, 2017 | 3.193B |
| December 31, 2016 | -2.563B |
| September 30, 2016 | -890.00M |
| June 30, 2016 | -1.498B |
| March 31, 2016 | 1.741B |
| December 31, 2015 | -617.00M |
| September 30, 2015 | -61.00M |
| June 30, 2015 | 2.525B |
| March 31, 2015 | -6.605B |
| December 31, 2014 | 7.204B |
| September 30, 2014 | -3.722B |
| June 30, 2014 | -49.00M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Johnson & Johnson | -2.709B |
| Eli Lilly & Co. | -8.299B |
| Pfizer Inc. | -2.026B |
| Bristol Myers Squibb Co. | -2.104B |
| Abbott Laboratories | -385.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 6.558B |
| Cash from Financing (Quarterly) | -2.432B |
| Free Cash Flow | 14.75B |
| Free Cash Flow Per Share (Quarterly) | 2.227 |
| Free Cash Flow to Equity (Quarterly) | 5.647B |
| Free Cash Flow to Firm (Quarterly) | 6.016B |
| Free Cash Flow Yield | 4.06% |